Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
Post
-
-
Perceptive, Nucleus partner to support radiopharmaceutical development
Perceptive Discovery and Nucleus RadioPharma have announced a non-exclusive strategic partnership to assist radiopharmaceutical developers shift from initial target validation through …
-
FDA grants 510(k) clearance for Urolution Medical’s OpenFlo catheter
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Urolution Medical’s OpenFlo urinary catheter. Cleared for adult use, …
-
Perceive Bio concludes Phase IIa trial enrolment for GA
Perceive Biotherapeutics (Perceive Bio) has concluded enrolment ahead of targets in its Phase IIa JOURNEY clinical study evaluating VOY-101, an …
-
SurGenTec signs licence deal with Allevion for Vantage
US-based medical device company SurGenTec has entered into an exclusive licence agreement with Allevion Medical to acquire the rights to …
-
Viome PRO introduces blood test for pancreatic cancer
Viome Life Sciences’ clinical division Viome PRO has launched CancerDetect Pancreatic, a physician-ordered blood test designed to identify pancreatic ductal …
-
Healthcare in 2022: what you need to know
With the Covid-19 pandemic sending shockwaves in the hospital sector, healthcare providers will continue looking for ways to slowly rebuild …
-
Alpheus begins multi-centre study for butterfly GBM
Alpheus Medical has begun the multi-centre Butterfly study to assess its investigational Porphyrin Metabolite Activation (PoMA) therapy in patients with …
-
Biohaven partners with Ono in $100m IgG degrader deal
Biohaven has entered into an exclusive regional collaboration and licensing agreement worth up to $100m with Ono Pharmaceutical for its …
-
The pitfalls in hospitals’ ability to auction clinical labour
Dr Michael Suk, founder and CEO of MDEnvoy, outlines the issues and potential solutions to premium labour bidding practices in …
-
BD reports nine-month AGILITY trial data for Revello stent
Becton, Dickinson and Company (BD) has reported nine-month clinical findings from the iliac cohort of its AGILITY Investigational Device Exemption …
-
Dignify Therapeutics secures FDA clearance for Phase I DTI-117 trial
Dignify Therapeutics has secured investigational new drug (IND) clearance from the US Food and Drug Administration (FDA) to advance DTI-117 …
-
10x Genomics and Fred Hutch partner on cancer technologies
10x Genomics has entered into a multi-project research agreement with Fred Hutchinson Cancer Center (Fred Hutch) for advancing single cell …
-
Cambridge Heartwear receives $243m tender for HeartSense wearable
The UK National Health Service (NHS) Supply Chain has awarded £184m ($243.7m) tender to Cambridge Heartwear to supply its HeartSense …
-
Viking Therapeutics begins study of oral VK2735 for obesity
Viking Therapeutics has commenced the second part of a clinical trial evaluating oral maintenance dosing schedules of its dual glucagon-like …
-
Gilead Sciences signs five-year DevOps agreement with Cognizant
Gilead Sciences has signed a five-year agreement extension with Cognizant to advance its DevOps environment and support the deployment of …
-
FDA clears Abbott’s CardioMEMS HF system updates
Abbott has received approval from the US Food and Drug Administration (FDA) for its CardioMEMS HF System capabilities, introducing new …
